Oberursel, Germany

Wolfgang Möller

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wolfgang Möller: Innovator in Antibody Preparation

Introduction

Wolfgang Möller is a notable inventor based in Oberursel, Germany. He has made significant contributions to the field of medical science, particularly in the development of antibody preparations. With a total of four patents to his name, Möller is recognized for his innovative approaches to treating viral infections.

Latest Patents

Möller's latest patents focus on methods of treating viral infections by administering an antibody preparation that comprises IgG, IgA, and IgM. One of his key inventions is an antibody preparation suitable for intravenous administration in humans. This preparation includes IgG, IgA, and at least 5% IgM antibodies by weight of the total amount of antibodies. It is prepared from human plasma and exhibits specific complement activating activity. In an in vitro assay with human serum, the antibody preparation generates substantially no C5a and/or substantially no C3a, indicating its potential for medical applications.

Career Highlights

Möller is currently associated with Biotest AG, where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that leverage the body's immune response to combat viral infections. His innovative spirit and dedication to medical science have positioned him as a key figure in his field.

Collaborations

Möller collaborates with esteemed colleagues such as Dieter Rudnick and Oliver Maneg. Their combined expertise fosters an environment of innovation and progress in the development of antibody therapies.

Conclusion

Wolfgang Möller's contributions to the field of antibody preparation highlight his commitment to advancing medical science. His innovative patents and collaborations reflect his dedication to improving treatment options for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…